Article Text
Therapeutics
Cross-over randomised controlled trial
Long-acting β-agonist step-up therapy is more likely to provide best response, compared to inhaled corticosteroid or leukotriene-receptor antagonist step-up in children with uncontrolled asthma receiving inhaled corticosteroids
Statistics from Altmetric.com
Footnotes
-
Competing interests MT received consulting fees from MSD, Schering, Novartis and GSK and received honoraria from Altana, Astra Zeneca, Boehringer Inglehiem, GSK, MSD, Merck Respiratory, Schering-Plough and Teva. He also received funding for research projects from GSK, MSD, Astra Zeneca and currently holds a research fellowship from Asthma UK.